1. OP0059 Golimumab versus tocilizumab for severe and refractory juvenile idiopathic arthritis-uveitis. multicenter study of 33 patients. (15th June 2017) Authors: Casas, L Domínguez; Calvo-Río, V; Calvo, I; González-Fernández, M; Lόpez-Montesinos, B; Mesquida, M; Adán, A; Hernández, M; Maíz, O; Blanco, A; Atanes, A; Bravo, B; Modesto, C; Díaz-Soriano, G; Coma, M Cordero; Díaz-Valle, D; Fernández-Cid, C; Cruz, J; Moreno, O Ruiz; González-Vela, M Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗